https://dxm-atlas.org/en/interactions/nefazodone/
CompareKey points for this combination
Serotonergic effects and CYP3A inhibition. Hepatotoxicity is described for nefazodone itself.
General concepts in this text
Serotonin
A neurotransmitter: a substance that carries a chemical signal from a nerve cell.
There are different serotonin receptors in the brain and other parts of the body. The response to the signal depends on the receptor and its location.
Sources: Serotonin
- OpenStax: Neural Communication · Introduction to Behavioral Neuroscience, published 2024-11-13
- OpenStax: Neurotransmitters Made from Amino Acids — Serotonin · Introduction to Behavioral Neuroscience, published 2024-11-13
CYP3A
A group of related CYP enzymes involved in the chemical transformation of medicines.
CYP3A is an enzyme group that includes CYP3A4 and CYP3A5.
Sources: CYP3A
- Daly: Significance of the minor cytochrome P450 3A isoforms · Clin Pharmacokinet. 2006;45(1):13–31; DOI 10.2165/00003088-200645010-00002; PMID 16430309
Hepatotoxicity
Liver injury caused by a toxic substance.
Possible sources include medicines, chemicals, herbal products and dietary supplements.
Sources: Hepatotoxicity
- NIH NIDDK LiverTox: Glossary, hepatotoxicity · Bookshelf NBK548773 PDF, page 4 of 8; retrieved 2026-10-13; separate entry revision unavailable
How well is this understood?
Mechanism confidence: medium
Confidence in the mechanism: medium
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
Can the amount reaching the body change?
ⓘ
CYP3A
A group of related CYP enzymes involved in the chemical transformation of medicines.
CYP3A is an enzyme group that includes CYP3A4 and CYP3A5.
Sources: CYP3A
- Daly: Significance of the minor cytochrome P450 3A isoforms · Clin Pharmacokinet. 2006;45(1):13–31; DOI 10.2165/00003088-200645010-00002; PMID 16430309
How can the effects add up?
ⓘ
SERT
A transporter protein involved in serotonin reuptake.
Inhibiting transport differs from acting on receptors.
Sources: SERT
- IUPHAR Pharmacology Education Project: Receptors · Live page accessed 2026-10-12; revision label unavailable
ⓘ
Receptor
A protein that binds particular molecules and participates in a cell response.
Different receptors have different functions.
Sources: Receptor
- IUPHAR Pharmacology Education Project: Receptors · Live page accessed 2026-10-12; revision label unavailable